Have a feature idea you'd love to see implemented?
Let us know!
RANI Rani Therapeutics Holdings Inc
Price (delayed)
$2.39
Market cap
$127.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.18
Enterprise value
$158.38M
Highlights
The EPS has increased by 14% YoY and by 9% from the previous quarter
The net income has grown by 11% YoY and by 8% from the previous quarter
The company's equity has shrunk by 88% YoY and by 62% QoQ
The quick ratio has dropped by 86% year-on-year and by 37% since the previous quarter
Key stats
What are the main financial stats of RANI
Market
Valuations
Earnings
Shares outstanding
53.41M
Market cap
$127.64M
Enterprise value
$158.38M
Price to earnings (P/E)
N/A
Price to book (P/B)
42.51
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$25.4M
EBITDA
-$23.46M
Free cash flow
-$45.97M
Per share
Balance sheet
Liquidity
EPS
-$1.18
Free cash flow per share
-$1.75
Book value per share
$0.06
Revenue per share
$0
TBVPS
$1.66
Total assets
$43.73M
Total liabilities
$38.18M
Debt
$35.25M
Equity
$2.84M
Working capital
$15.45M
Debt to equity
12.43
Current ratio
1.93
Quick ratio
1.86
Net debt/EBITDA
-1.31
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-54.2%
Return on equity
-300.9%
Return on invested capital
-35.1%
Return on capital employed
-93.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RANI stock price
How has the Rani Therapeutics Holdings stock price performed over time
Intraday
-5.16%
1 week
-9.13%
1 month
8.64%
1 year
19.5%
YTD
-28.01%
QTD
10.65%
Financial performance
How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$57.85M
Net income
-$30.58M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 16% YoY and by 9% from the previous quarter
The net income has grown by 11% YoY and by 8% from the previous quarter
Growth
What is Rani Therapeutics Holdings's growth rate over time
Valuation
What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
42.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 14% YoY and by 9% from the previous quarter
The company's equity has shrunk by 88% YoY and by 62% QoQ
RANI's P/B is 58% above its last 4 quarters average of 26.9
Efficiency
How efficient is Rani Therapeutics Holdings business performance
Rani Therapeutics Holdings's return on equity has shrunk by 193% YoY and by 41% QoQ
The ROA has plunged by 56% YoY and by 9% from the previous quarter
RANI's ROIC is down by 13% YoY and by 4.5% from the previous quarter
Dividends
What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RANI.
Financial health
How did Rani Therapeutics Holdings financials performed over time
Rani Therapeutics Holdings's total assets is 15% more than its total liabilities
The current ratio has shrunk by 86% YoY and by 38% QoQ
The quick ratio has dropped by 86% year-on-year and by 37% since the previous quarter
The company's debt to equity has surged by 159% QoQ
The company's equity has shrunk by 88% YoY and by 62% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.